73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Refined method to peer into cancer cells' inner working unlocks the interactome

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR
Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer
Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu
Research into use of diabetes medication for treatment of metastatic prostate cancer

Research into use of diabetes medication for treatment of metastatic prostate cancer

byMedical University of ViennaCredit: AI-generated imagePatients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of

Research into use of diabetes medication for treatment of metastatic prostate cancer

byMedical University of ViennaCredit: AI-generated imagePatients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of
Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha
Protein movement reveals brain tumor's weak spot

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel
Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati
Head and neck cancer survivors at increased risk of suicide

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated
Gene mutations should be tested routinely for ovarian cancer, say scientists

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel